[HTML][HTML] Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik, IA Pasaribu… - BMC Endocrine …, 2023 - Springer
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
[PDF][PDF] Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik, IA Pasaribu, RP Adiwinoto… - 2023 - researchgate.net
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin.
AM Wahono, T Harnanik, IA Pasaribu… - BMC Endocrine …, 2023 - europepmc.org
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik, IA Pasaribu… - BMC Endocrine …, 2023 - search.proquest.com
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
[HTML][HTML] Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik, IA Pasaribu… - BMC Endocrine …, 2023 - ncbi.nlm.nih.gov
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik, IA Pasaribu… - BMC endocrine …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
[HTML][HTML] Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik… - BMC …, 2023 - bmcendocrdisord.biomedcentral …
Diabetic nephropathy (DN) represents a microvascular complication of diabetes mellitus
(DM). Despite the increasing incidence and prevalence of DN, conservative therapy only …
(DM). Despite the increasing incidence and prevalence of DN, conservative therapy only …
Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin.
AM Wahono, T Harnanik, IA Pasaribu… - BMC Endocrine …, 2023 - search.ebscohost.com
Background: Diabetic nephropathy (DN) represents a microvascular complication of
diabetes mellitus (DM). Despite the increasing incidence and prevalence of DN …
diabetes mellitus (DM). Despite the increasing incidence and prevalence of DN …
[PDF][PDF] Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin
AM Wahono, T Harnanik, IA Pasaribu… - 2023 - bmcendocrdisord.biomedcentral …
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
Laboratory and clinical findings in mouse models of diabetic nephropathy induced with streptozotocin.
AM Wahono, T Harnanik, IA Pasaribu… - BMC Endocrine …, 2023 - europepmc.org
Background Diabetic nephropathy (DN) represents a microvascular complication of diabetes
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …
mellitus (DM). Despite the increasing incidence and prevalence of DN, conservative therapy …